Takeda, Sea Lane Shake Hands On Two-Year Technology Deal
By Catherine Shaffer
Thursday, June 13, 2013
Takeda California Inc., of San Diego, a subsidiary of Takeda Pharmaceutical Co. Ltd., partnered with Sea Lane Biotechnologies, of Mountain View, Calif., giving Takeda access to Sea Lane's Concirt human antibody libraries for its drug discovery program in exchange for an up-front payment and milestone option fees for projects initiated under the collaboration.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.